Skip to main content
. 2022 Dec 13;14(12):2790. doi: 10.3390/pharmaceutics14122790

Figure 1.

Figure 1

Defective Zr-MOFs: (a) Structure and (b) cell viability. Reproduced with permission from Ref. [68], copyright (2018) the Royal Society of Chemistry. (c) Preparation of Ibu@UiO-66-NH2 and its application. (df) Characterization and drug release of UiO-66-NH2 and Ibu@UiO-66-NH2. Reproduced with permission from Ref. [69], copyright (2019) the American Chemical Society.